AEMD stock: buy or sell?
May 21st, 2019
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide.
Should I buy AEMD stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Aethlon Medical stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Aethlon Medical stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for AEMD stock for the last month.
AEMD stock analysis
Aethlon Medical shares plummed -4.76% to $0.40 today.
Aethlon Medical shares plummed -4.76% to $0.40 today. Since price and SMA200d lines crossed down on February, AEMD fell $-0.97 per share (-70.80%). AEMD marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $0.85 would break this short term down trend and open possibilities for reversing this situation.
After sliding a chilling -14.29% in a week last week, Aethlon Medical closed this week at $0.40 and plummed a godawful -4.76%. This was the fourth red week in a row, sliding in full a -49.30%. Late April AEMD climbed a superb 5.33% in just one week.
Aethlon Medical is now in fresh lows to find new supports after falling under the support. Since price and 40-weeks moving average lines crossed down by mid February, AEMD fell $-0.96 per share (-70.59%). Stocks under the 200 days moving average line are usually not recommended for average traders.
AEMD stock price history
AEMD IPO was on February 11th, 2002 at $65.00 per share1. Since then, AEMD stock sliced a -99.40%, with a yearly average of -5.80%.
1: Adjusted price after possible price splits or reverse-splits.
AEMD stock historical price chart
AEMD stock reached 52-week highs on November at $1.74, and all-time highs 2004-03-09 with a price of 212.5.
AEMD stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' AEMD stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not found any price forecast for Aethlon Medical stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAethlon Medical reported super good results for 2018-Q4 on February. Aethlon Medical climbed Earnings per Share (EPS) by 57.10%, beating analysts estimates of $-0.07. Aethlon Medical posted $-0.11.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw a frightening slide of -61.84% to $0.15 M dollars. Similarly, its profit margin (compared to revenues) plummed to -3,795.86%, that is $-5.68 million. To have an up to date view of the financial situation of Aethlon Medical, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2018-Q4 that can be compared to 2018 fiscal year results. Annual Aethlon Medical TTM sales up to December 2018 were $0.22 and income was $-5.87 million dollars. If we compare this TTM figures with the last reported annuality, we can esteem Aethlon Medical business evolution since March 2018: Annual sales up to December, compared to lastest yearly report, rocketed an extraordinary 50.00%. In line, profit margin (net income/revenues) skyrocketed at -3,795.86%.
|2013||$1.23 M||-||$-4.89 M-397.6%||-|
|2014||$1.62 M||31.71%||$-13.36 M-824.7%||173.21%|
|2015||$0.76 M||-52.94%||$-6.80 M-891.5%||-49.12%|
|2016||$0.89 M||16.28%||$-4.87 M-549.6%||-28.32%|
|2017||$0.39 M||-55.78%||$-7.28 M-1855.8%||49.34%|
|2018||$0.15 M||-61.84%||$-5.68 M-3795.9%||-21.94%|
|TTM||$0.22 M||50.00%||$-5.87 M-2616.1%||3.38%|
Quarterly financial resultsReported quarter earnings marked $-2.01 M with a profit margin of . Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing revenues to same quarter last year, Aethlon Medical sales marked a hair-raising loss and collapsed a -100.00%. Looking back to recent quarterly results, Aethlon Medical posted 2 negative quarters in a row.
|2017-Q4||$0.07 M||-||$-1.22 M-1624.1%||-|
|2018-Q1||$0.07 M||0.00%||$-1.32 M-1762.9%||8.55%|
|2018-Q2||$0.15 M||100.00%||$-1.15 M-766.1%||-13.09%|
Aethlon Medical ownershipWhen you are planning to buy shares of a company, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Aethlon Medical, 6.64% of all outstanding shares are owned by its staff.
In case of Aethlon Medical stock, 14.95% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for AEMD stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related stocks:
|Market cap||$7.6 M||$1.0 B||$19.6 M||$6.5 B||$2.9 B|
|Total shares||19.0 M||54.5 M||10.5 M||156.8 M||24.2 M|
|Float shares||17.7 M||26.6 M||6.9 M||103.2 M||23.9 M|
|- Institutional holdings (%)||14.9%||50.2%||12.3%||68.7%||101.1%|
|- Insider holdings (%)||6.6%||46.2%||28.6%||34.4%||1.2%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Tuesday, May 21st, 2019|
|Day range||$0.38 - $0.43|
|Average true range||$0.09|
|50d mov avg||$0.79|
|100d mov avg||$1.02|
|200d mov avg||$1.09|
Aethlon Medical performanceTo measure stock performance is always good to benchmark with competitors or related stocks. For Aethlon Medical, the comparison is made against Accelerate Diagnostics, Bioanalytical Systems, Bruker, Coherent, Inovio Pharmaceuticals, Pacific Biosciences of California and PerkinElmer.